Ingredion Inc
NYSE:INGR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
106.46
154.86
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Ingredion Inc
Wall Street
Price Targets
INGR Price Targets Summary
Ingredion Inc
According to Wall Street analysts, the average 1-year price target for
INGR
is 168.5 USD
with a low forecast of 148.47 USD and a high forecast of 186.9 USD.
INGR Last Price Targets
Ingredion Inc
The latest public price target was made on Oct 21, 2024 by
Kristen Owen
from
Oppenheimer
,
who expects
INGR
stock to
rise by 6%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Kristen Owen
Oppenheimer
|
147
USD
Upside 6% |
2 months ago
Oct 21, 2024
|
Ingredion (INGR) PT Raised to $147 at Oppenheimer
StreetInsider
|
Benjamin Theurer
Barclays
|
145
USD
Upside 5% |
4 months ago
Aug 9, 2024
|
Ingredion upgraded to Overweight from Equal Weight at Barclays
TheFly
|
|
Kristen Owen
Oppenheimer
|
138
USD
Downside 0% |
4 months ago
Aug 7, 2024
|
Ingredion (INGR) PT Raised to $138 at Oppenheimer
StreetInsider
|
Andrew Strelzik
BMO Capital
|
128
USD
Downside 8% |
4 months ago
Aug 7, 2024
|
Ingredion (INGR) PT Raised to $128 at BMO Capital
StreetInsider
|
|
Andrew Strelzik
BMO Capital
|
120
USD
Downside 13% |
7 months ago
May 9, 2024
|
Ingredion (INGR) PT Raised to $120 at BMO Capital
StreetInsider
|
|
Kristen Owen
Oppenheimer
|
126
USD
Downside 9% |
7 months ago
May 8, 2024
|
Ingredion (INGR) PT Raised to $126 at Oppenheimer
StreetInsider
|
|
Kristen Owen
Oppenheimer
|
120
USD
Downside 13% |
1 year ago
Sep 29, 2023
|
Ingredion's Growth Strategy To Please Health-Conscious Consumers Can Make It A Winner: Analyst
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is INGR's stock price target?
Price Target
168.5
USD
According to Wall Street analysts, the average 1-year price target for
INGR
is 168.5 USD
with a low forecast of 148.47 USD and a high forecast of 186.9 USD.
What is Ingredion Inc's Revenue forecast?
Projected CAGR
-1%
For the last 8 years the
compound annual growth rate for
Ingredion Inc's revenue is
5%.
The projected
CAGR
for the next 4 years is
-1%.
What is Ingredion Inc's Operating Income forecast?
Projected CAGR
2%
For the last 8 years the
compound annual growth rate for
Ingredion Inc's operating income is
4%.
The projected
CAGR
for the next 4 years is
2%.
What is Ingredion Inc's Net Income forecast?
Projected CAGR
3%
For the last 8 years the
compound annual growth rate for
Ingredion Inc's net income is
6%.
The projected
CAGR
for the next 4 years is
3%.
You don't have any saved screeners yet
